OrthoSpace enrolls 1st set of patients in IDE study: 5 things to know

OrthoSpace has enrolled the first three patients in its United States investigational device exemption pivotal study.

Advertisement

Here are five things to know:

 

1. The study will compare the company’s InSpace product to conventional repair or partial repair for the treatment of full thickness massive rotator cuff tears.  

 

2. InSpace is an orthopedic biodegradable balloon system.

 

3. The IDE study will include 184 subjects.

 

4. The system has been implanted in more than 5,000 patients in 15 countries.

 

5. Edwin J. Rogusky, MD, and Paul R. Sensiba, MD, performed the procedures at University Orthopedics Center in State College, Pa. It was the first time the balloon has been implanted in the United States.

 

More articles on devices:
15 things to know about Zimmer Biomet
DePuy Synthes invests $60M in expanded manufacturing plant in Ireland: 4 things to know
3D Systems named to top 50 ‘smartest companies’ list: 5 observations

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.